Skip to main content

REMS vs DEXA

REMS and DEXA both measure bone density at your spine and hip. DEXA does it with X-rays and is the insurance-covered standard. REMS does it with ultrasound, and adds a validated score for the structural quality of your bone.

Dr. Krystyna ShepetiukWritten by Dr. Krystyna Shepetiuk, PharmD, CDCES, IFM9 peer-reviewed sourcesLast reviewed: August 18, 2026

The Technology

How REMS and DEXA actually work

Answer:DEXA passes two low-dose X-ray beams through bone and calculates density from how much of the beam the bone absorbs. REMS sends ultrasound pulses into the same spine and hip sites and analyzes the raw echo spectrum, reading both mineral density and the structural quality of bone — by ultrasound.

DEXA

Dual-Energy X-ray Absorptiometry · since 1987

Two X-ray beams at different energy levels pass through your lumbar spine and hip. Because bone and soft tissue absorb the beams differently, the scanner computes your bone mineral density in g/cm², expressed as a T-score against a healthy 30-year-old reference.

It measures the image of your bone — which is exactly why anything that changes the image (arthritis, calcified vessels, compressed vertebrae, metal) changes the number.

REMS

Radiofrequency Echographic Multi-Spectrometry · FDA-cleared

An ultrasound probe at the same spine and hip sites captures raw, unfiltered echo signals. Software compares their full radiofrequency spectrum against reference models, producing the same T-score and Z-score as DEXA — plus a Fragility Score for bone quality.

It measures the tissue itself rather than an image of it, so the artifacts that distort X-ray densitometry are largely discarded in the signal analysis.

Head to Head

REMS vs DEXA, category by category

Answer:REMS and DEXA agree closely on bone density itself — REMS matched DEXA with 90.4% sensitivity and 95.5% specificity across 4,307 women. They diverge on everything around the number: REMS adds bone quality, repeats freely, and resists artifacts; DEXA keeps insurance coverage and guideline status.

Both return a T-score at the same two skeletal sites. Only REMS adds a separate bone-quality reading on top of density.

In this category: 1 REMS advantage · 0 DEXA advantages · 4 comparable

  • Physical principleREMSUnfiltered ultrasound echo signals, analysed spectrallyDEXATwo X-ray beams at different energies, measuring attenuationComparable
  • Skeletal sitesREMSLumbar spine (L1–L4) and femoral neckDEXALumbar spine (L1–L4) and hipComparable
  • Primary outputREMSBMD in g/cm², T-score, Z-scoreDEXABMD in g/cm², T-score, Z-scoreComparable
  • Bone quality readingREMSFragility Score (0–100) included in every scanDEXANot included — requires separate TBS software licenceREMS advantage
  • WHO diagnostic criteriaREMST-score reported against WHO thresholdsDEXAT-score reported against WHO thresholdsComparable

Why Precision Matters

Your bones deserve better than an average

Answer:Precision decides how soon you can trust a change in your bones. REMS reproduces its own measurement to within roughly 0.4%, while a repeat DEXA can vary enough that small changes may be measurement noise. Higher precision means real change shows sooner — which makes personalized, data-driven prevention practical.

A population statistic is not a plan

A T-score compares your bone to an average 30-year-old’s. That is a useful screening convention, but it flattens you into a percentile. Two women with the identical T-score of −1.8 can carry very different fracture risks — one with dense-but-brittle bone, one with less-dense-but-well-structured bone. Density alone cannot tell them apart; in a 5-year study of 1,989 adults, the REMS Fragility Score separated who fractured from who did not better than either technology’s T-score. Personalization starts with measuring the individual, not ranking them.

Noise is the enemy of feedback

Bone changes slowly — a good year of training and nutrition might move density a few percent. If your instrument’s scan-to-scan variability is of the same size as the change you are trying to detect, you are flying blind: an encouraging result may be noise, a discouraging one may be noise too. This is why DEXA guidelines require each facility to calculate its own “least significant change” before trend claims are made, and why comparisons across different DEXA machines are unreliable. REMS’s published precision error of 0.32–0.38% leaves room for a real signal to emerge above the noise floor — the difference between guessing and knowing whether your protocol works.

Measurement you can repeat becomes a feedback loop

A scan you take once a decade is a verdict. A scan you can repeat — safely, affordably, as often as your care calls for — is a feedback loop: baseline, intervene, re-measure, adjust. That loop is the entire logic of personalized prevention, and ultrasound measurement is what makes it possible. It is the difference between being told at 68 that you have osteoporosis and watching your own trajectory from 45 — while there is still time to bend the curve.

The Honest Part

Where DEXA still wins

Answer:DEXA remains the reference standard for diagnosing osteoporosis and the measurement treatment guidelines are written around. Insurance, including Medicare, covers it; prescribing thresholds use its T-scores; and decades of outcome data stand behind it. If medication or insurance authorization is on the table, you will need a DEXA scan.

  • It is the standard your treatment will be judged against

    FRAX inputs, medication thresholds, and monitoring protocols are built on DEXA-derived BMD. A REMS report informs the conversation; it does not currently substitute in those pathways.

  • Insurance covers it

    Medicare covers DEXA for eligible adults, and most insurers follow. REMS is typically self-pay. If cost is the deciding factor and you qualify, DEXA is the rational first scan.

  • Its evidence base is decades deep

    Every major osteoporosis drug trial used DEXA endpoints. REMS validation is strong and growing — roughly a decade of published studies — but it cannot yet match that historical depth.

  • Specific populations are better characterized on DEXA

    In disuse-related osteoporosis (for example after spinal cord injury), an independent study found poor REMS–DEXA concordance. Honest limits are limits: for these patients, DEXA remains the better-understood tool.

The Evidence

What the research actually shows

Answer:Peer-reviewed studies from 2018 to 2025 validate REMS against DEXA at the spine and hip, document its precision, and show its Fragility Score predicting five-year fracture risk more accurately than either technology’s T-score. Independent groups also report disagreement in specific populations, cited below alongside the supporting data.

90.4%

sensitivity vs DEXA at the femoral neck (n=4,307)

Cortet 2020

0.32%

REMS precision error at the femur — vs facility-dependent DEXA

Di Paola 2018

0.811

Fragility Score AUC for 5-year fracture prediction in women

Pisani 2023

58.7%

of fractured patients flagged by REMS when DEXA was artifact-inflated (vs 23.3%)

Caffarelli 2022

Sources

  1. [1]

    Di Paola M, et al. (2018). Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck. Osteoporosis International.

    1,914 women. REMS short-term precision (RMS-CV): 0.38% at the spine, 0.32% at the femur. Mean BMD difference vs DEXA: −0.004 g/cm² (spine).

  2. [2]

    Diez-Perez A, Brandi ML, et al. (2019). Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art — ESCEO expert consensus. Aging Clinical and Experimental Research.

    European Society (ESCEO) consensus: REMS is a valuable approach for osteoporosis diagnosis and fracture risk prediction on axial sites.

  3. [3]

    Adami G, et al. (2020). Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: a 5-year follow-up study. Bone.

    1,370 women followed up to 5 years. At the spine, REMS T-score identified women who went on to fracture with OR 2.6 vs 1.7 for DEXA.

  4. [4]

    Cortet B, Dennison E, Diez-Perez A, et al. (2020). REMS for the diagnosis of osteoporosis in a European multicenter clinical context. Bone.

    4,307 women, ages 30–90. Against DEXA: 90.4% sensitivity / 95.5% specificity at the femoral neck; 90.9% / 95.1% at the lumbar spine.

  5. [5]

    Caffarelli C, et al. (2022). Could REMS overcome the overestimation in BMD by DXA at the lumbar spine?. BMC Musculoskeletal Disorders.

    In 159 women with artifact-inflated lumbar DEXA: REMS classified 58.7% of previously fractured patients as osteoporotic vs 23.3% by DEXA.

  6. [6]

    Lalli P, et al. (2022). Reproducibility and accuracy of REMS for femoral BMD estimation in primary and disuse-related osteoporosis. Journal of Clinical Medicine.

    Dissenting data: diagnostic concordance with DEXA was only 63% in primary osteoporosis and 13% in disuse-related osteoporosis, with excellent test–retest reproducibility.

  7. [7]

    Pisani P, Conversano F, et al. (2023). Fragility Score: a REMS-based indicator for the prediction of incident fragility fractures at 5 years. Aging Clinical and Experimental Research.

    1,989 adults. The Fragility Score predicted osteoporotic fractures with AUC 0.811 (women) and 0.780 (men) — higher than both REMS and DEXA T-scores (AUC 0.472–0.709).

  8. [8]

    Fuggle NR, Reginster JY, et al. (2024). REMS in the diagnosis and management of osteoporosis: state of the art. Aging Clinical and Experimental Research.

    Review: strong DEXA correlation, 5-year fracture prediction via Fragility Score, and suitability for underserved groups (pregnancy, frailty, bedside).

  9. [9]

    Zambito K, Kushchayeva Y, Bush A, et al. (2025). Proposed practice parameters for the performance of REMS evaluations. Bone & Joint Open.

    US clinical practice parameters: REMS is as accurate as quality-assured DEXA for axial BMD, and BMD alone is a poor predictor of fracture risk.

Study records verified via PubMed (August 2026). Each citation links to the publisher’s version of record via DOI.

Your Situation

Which scan is right for you?

Answer:Choose REMS for an ultrasound baseline, frequent monitoring, or when arthritis and prior fractures could distort a DEXA reading. Choose DEXA when insurance coverage or medication qualification drives the decision. Many people benefit from both: DEXA for the medical record, REMS for the fuller, more frequent picture.

Choose the line that sounds most like you.

REMS bone assessment is a screening tool for adults concerned about bone health and is not a replacement for diagnostic imaging ordered by a physician. Individuals currently under active treatment for osteoporosis should discuss REMS results with their treating physician. REMS results do not replace DEXA scans required for insurance-mandated treatment monitoring.

Questions

REMS vs DEXA — frequently asked

For measuring bone density, yes — within well-studied limits. In a European multicenter study of 4,307 women, REMS identified osteoporosis with 90.4% sensitivity and 95.5% specificity at the femoral neck compared against DEXA, with similar results at the spine. REMS also reproduces its own measurement more tightly (0.32–0.38% precision error). One independent study found lower diagnostic concordance in disuse-related bone loss, so DEXA remains preferred in that specific population.

Not for every purpose. If your physician needs a scan to qualify you for osteoporosis medication, or your insurer requires DEXA for treatment monitoring, you will still need a DEXA — prescribing guidelines and coverage rules are written around it. REMS works alongside DEXA: it adds a bone-quality reading (Fragility Score), lifts the constraint on how often you can repeat the reading, and provides a second opinion when a DEXA result looks inconsistent with your history.

Two common reasons. First, artifacts: spinal arthritis, bone spurs, and aortic calcification all add apparent density to a DEXA image, so a fragile spine can read as normal. Second, density is not the whole story — fracture resistance also depends on bone microarchitecture, which standard DEXA does not measure. In one study of women with artifact-inflated DEXA readings, REMS reclassified 58.7% of previously fractured patients as osteoporotic, versus 23.3% by DEXA.

The Fragility Score is a 0–100 index of bone structural quality, computed from the raw ultrasound spectrum during a REMS scan — lower is better. In a 5-year study of 1,989 adults, it predicted incident osteoporotic fractures with an AUC of 0.811 in women and 0.780 in men, outperforming both the REMS and DEXA T-scores in the same cohort. It answers a different question than density: not how much bone you have, but how well that bone is likely to hold.

Ultrasound — the same class used in prenatal imaging. That is why it can be repeated as often as clinically useful, and why it is an option during pregnancy, when DEXA is not performed. DEXA is an X-ray method, which is one reason DEXA scans are typically spaced 1–2 years apart.

Increasingly, yes. REMS reports T-scores and Z-scores using the same WHO diagnostic thresholds as DEXA, US practice parameters for REMS evaluations were published in 2025, and the technology is FDA-cleared. Many physicians use REMS results as complementary information alongside DEXA. Bring your full REMS report to your appointment — and note that for insurance-mandated treatment decisions, your physician may still order a DEXA.

DEXA monitoring is typically spaced 12–24 months apart — partly because of how an X-ray method is dosed, and partly because its scan-to-scan variability means small changes cannot be distinguished from measurement noise sooner. REMS is an ultrasound reading and reproduces its measurement to within roughly 0.4%, so the re-scan interval becomes a clinical decision rather than a safety constraint. Many people tracking an intervention re-scan every 6–12 months.

DEXA is usually the cheaper option out of pocket if you qualify for coverage: Medicare and most insurers cover it for women 65+, men 70+, and younger adults with risk factors. REMS is typically self-pay — at HALLĒ, a complete REMS bone health assessment is $325, is HSA/FSA eligible, requires no referral, and includes bone density, the Fragility Score, and a same-day results review.

Ultrasound · Same-Day Results

See both sides of your bone health

Density and quality, measured in one 30-minute visit — with a same-day review of what your numbers mean and what to do next.

FDA-cleared technology6,000+ scans performedHSA/FSA eligible

This screening process is for educational and informational purposes only and does not constitute medical diagnosis.

Starting at $325HSA/FSA